Stock Events

Stock Events

MindMaze Therapeutics SA 

$0.2221
83
+$0.01+3.41% Friday 16:44

Statistics

Day High
0.18
Day Low
0.18
52W High
4.88
52W Low
0.161
Volume
5
Avg. Volume
4,585
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MMTZF. It's not an investment recommendation.
Apple
10
AAPL
Tesla
9
TSLA
Microsoft
8
MSFT
AMD
6
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that competes in developing treatments for viral diseases, a similar area of focus as Relief Therapeutics.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is involved in developing medications for serious medical conditions, directly competing with Relief Therapeutics in the biopharmaceutical space.
Moderna
MRNA
Mkt Cap55.09B
Moderna is known for its mRNA technology used in vaccines and therapies, competing with Relief Therapeutics in the innovative treatment sector.
Pfizer
PFE
Mkt Cap159.36B
Pfizer develops and manufactures drugs and vaccines, including treatments for COVID-19, making it a competitor in the pandemic response market.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global biopharmaceutical company working on vaccines and treatments for various diseases, including COVID-19, competing with Relief Therapeutics.
BioNTech
BNTX
Mkt Cap25.64B
BioNTech SE, in partnership with Pfizer, developed a COVID-19 vaccine, directly competing with Relief Therapeutics' efforts in pandemic-related treatments.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division, develops treatments and vaccines, including for COVID-19, competing in the same space as Relief Therapeutics.
Novavax
NVAX
Mkt Cap1.53B
Novavax is focused on developing vaccines, including for COVID-19, making it a direct competitor in the vaccine development space.
Sorrento Therapeutics
SRNE
Mkt Cap385,896
Sorrento Therapeutics works on therapies for COVID-19, cancer, and pain, competing with Relief Therapeutics in multiple therapeutic areas.

About

MINDMAZE THRAPEUTICS HLDS
Show more...
CEO
Zach Henderson
Employees
10
Country
Switzerland
ISIN
CH1251125998
WKN
000A3EFB5

Listings

F
DE
V6M.F
MU
DE
V6M0.MU
LSE
GB
0QKQ.LSE
OTC Link
US
MMTZF

0 Comments

Share your thoughts

FAQ

What is MindMaze Therapeutics SA stock price today?▼
The current price of MMTZF is $0.22 USD — it has increased by +3.41% in the past 24 hours. Watch MindMaze Therapeutics SA stock price performance more closely on the chart.
What is MindMaze Therapeutics SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange MindMaze Therapeutics SA stocks are traded under the ticker MMTZF.
How many employees does MindMaze Therapeutics SA have?▼
As of September 05, 2026, the company has 10 employees.
In which sector is MindMaze Therapeutics SA located?▼
MindMaze Therapeutics SA operates in the Health & Wellness sector.
When did MindMaze Therapeutics SA complete a stock split?▼
MindMaze Therapeutics SA has not had any recent stock splits.
Where is MindMaze Therapeutics SA headquartered?▼
MindMaze Therapeutics SA is headquartered in Geneva, Switzerland.